Mustang Bio shareholders approve issuance of up to 5.48M shares underlying warrants

MUSTANG BIO, INC.

Written consent signed by holders of ~56% of voting power authorizing warrant share issuance under Nasdaq Rule 5635(d).
Issuance covers up to 5,475,082 shares of common stock underlying warrants issued to H.C. Wainwright & Co. and accredited investors.
Consent holders: 131,052 common shares and 250,000 Class A Preferred shares (each with ~8.4 votes).
Definitive information statement on Schedule 14C to be filed and sent to stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.